Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health claims meeting

This article was originally published in The Tan Sheet

Executive Summary

An FDA public meeting to assess consumer perceptions of health claims will be held Nov. 17 at the Center for Food Safety & Applied Nutrition Harvey Wiley Auditorium from 9 a.m. to 4:30 p.m., the agency announces in a Federal Register notice Oct. 19. The agency will present findings from research assessing consumer reactions to health claims and "address the implications of these studies for future research" evaluating the effect of health claims on consumer behavior. Those who wish to make presentations must register by Nov. 10. Comments also are being collected through Jan. 17. An FDA study on consumer reactions to health claims was recently released (1"The Tan Sheet" Oct. 10, 2005, p. 7)...
Advertisement

Related Content

Qualified Claims Language And Grading Confuses Consumers – FDA Study
Qualified Claims Language And Grading Confuses Consumers – FDA Study

Topics

Advertisement
UsernamePublicRestriction

Register

PS098757

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel